---
title: "The chemical pharmaceutical sector has declined in the short term, with CSBIO falling over 12%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245193120.md"
description: "The chemical pharmaceutical sector has seen a short-term decline, with CSBIO falling over 12%. YONGAN PHARMACEUTICAL, HYBIO, TONGHUA GOLDEN-HORSE, Cosunter, and others have also followed suit"
datetime: "2025-06-19T01:46:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245193120.md)
  - [en](https://longbridge.com/en/news/245193120.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245193120.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/245193120.md) | [繁體中文](https://longbridge.com/zh-HK/news/245193120.md)


# The chemical pharmaceutical sector has declined in the short term, with CSBIO falling over 12%

The chemical pharmaceutical sector has seen a short-term decline, with CSBIO dropping over 12%. YONGAN PHARMACEUTICAL, HYBIO, TONGHUA GOLDEN-HORSE, and Cosunter also followed suit

### Related Stocks

- [YONGAN PHARMACEUTICAL (002365.CN)](https://longbridge.com/en/quote/002365.CN.md)
- [HYBIO (300199.CN)](https://longbridge.com/en/quote/300199.CN.md)
- [TONGHUA GOLDEN-HORSE (000766.CN)](https://longbridge.com/en/quote/000766.CN.md)
- [Cosunter (300436.CN)](https://longbridge.com/en/quote/300436.CN.md)
- [CSBIO (300255.CN)](https://longbridge.com/en/quote/300255.CN.md)

## Related News & Research

- [Tajikistan Approves Hebei Changsha Biochemical Pharmaceutical's Thrombosis Injection](https://longbridge.com/en/news/278372421.md)
- [China's ByteDance gets access to top Nvidia AI chips, WSJ reports](https://longbridge.com/en/news/278976301.md)
- [Alert tagged to Wiz Co Participacoes e Corretagem de Seguros SA withdrawn](https://longbridge.com/en/news/278727963.md)
- [Clover Biopharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Dividend](https://longbridge.com/en/news/279032574.md)
- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/en/news/278461777.md)